Iterum Therapeutics PLC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Armistice Capital, LLC and Steven Boyd have disclosed a 4.99% beneficial ownership stake in Iterum Therapeutics plc, holding 1,445,158 ordinary shares as of December 31, 2024.